Serotonin transporter (SERT) and translocator protein (TSPO) expression in the obese ob/ob mouse

BMC Neuroscience

Volumn 12, Issue , 2011, Pages

  Giannaccini, Gino ^a   Betti, Laura ^a   Palego, Lionella ^a   Pirone, Andrea ^a   Schmid, Lara ^a   Lanza, Mario ^a   Fabbrini, Laura ^a   Pelosini, Caterina ^b   Maffei, Margherita ^b   Santini, Ferruccio ^b   Pinchera, Aldo ^b   Lucacchini, Antonio ^a  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY HOSPITAL OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE; CARRIER PROTEIN; CHOLESTEROL; LEPTIN; LIGAND; PAROXETINE; PROTEIN; SEROTONIN TRANSPORTER; 4 AMINOBUTYRIC ACID RECEPTOR; BZRP PROTEIN, MOUSE; SLC6A4 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BIOCHEMISTRY; CELL METABOLISM; CENTRAL NERVOUS SYSTEM; CHOROID PLEXUS; CONTROLLED STUDY; DENTATE GYRUS; HIPPOCAMPUS; MALE; MOUSE; NEUROTRANSMISSION; NEUROTROPISM; NONHUMAN; OBESITY; PROTEIN EXPRESSION; RADIOCHEMISTRY; THROMBOCYTE; UPREGULATION; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; COMPARATIVE STUDY; GENE EXPRESSION REGULATION; GENETICS; HYPOTHALAMUS; METABOLISM; MOUSE MUTANT; PROTEIN BINDING;

ANIMALS; GENE EXPRESSION REGULATION; HIPPOCAMPUS; HYPOTHALAMUS; LEPTIN; MALE; MICE; MICE, INBRED C57BL; MICE, OBESE; PAROXETINE; PROTEIN BINDING; RECEPTORS, GABA; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS;

EID: 79551649568     PISSN: None     EISSN: 14712202     Source Type: Journal    
DOI: 10.1186/1471-2202-12-18     Document Type: Article

References (33)

1. Lindström P. The physiology of obese-hyperglycemic mice [ob/ob mice]. The Sci World J 2007, 7:666-685.
2. Myers MG. Leptin receptor signaling and the regulation of mammalian physiology. Recent Prog Horm Res 2004, 59:287-304. 10.1210/rp.59.1.287, 14749507.
3. Saito M, Bray GA. Diurnal rhythm for corticosterone in obese (ob/ob) diabetes (db/db) and goldthioglucose-induced obesity in mice. Endocrinology 1983, 113:2181-2185. 10.1210/endo-113-6-2181, 6416815.
4. Beck B. Neuropetides and obesity. Nutrition 2000, 16:916-923. 10.1016/S0899-9007(00)00410-X, 11054597.
5. Collin M, Håkansson-Ovesjö ML, Misane I, Ögren SO, Meister B. Decreased 5-HT transporter mRNA in neurons of the dorsal raphe nucleus and behavioral depression in the obese leptin-deficient ob/ob mouse. Mol Brain Res 2000, 81:51-61. 10.1016/S0169-328X(00)00167-4, 11000478.
6. Murphy DL, Fox MA, Timpano KR, Moya PR, Patterson AM, Holmes A, Lesch KP, Wendland JR. How the serotonin story is being rewritten by new gene-based discoveries principally related to SLC6A4, the serotonin transporter gene, which functions to influence all cellular serotonin systems. Neuropharmacology 2008, 55:932-960. 10.1016/j.neuropharm.2008.08.034, 2730952, 18824000.
7. Batarseh A, Papadopoulos V. Regulation of translocator protein 18 kDa (TSPO) expression in health and disease states. Mol Cell Endocrinol 2010, 327:1-12. 10.1016/j.mce.2010.06.013, 20600583.
8. Falchi AM, Battetta B, Sanna F, Piludu M, Sogos V, Serra M, Melis M, Putzolu M, Diaz G. Intracellular cholesterol changes induced by translocator protein (18 kDa) TSPO/PBR ligands. Neuropharmacology 2007, 53:318-329. 10.1016/j.neuropharm.2007.05.016, 17631921.
9. Rone MB, Fan J, Papadopoulos V. Cholesterol transport in steroid biosynthesis: role of protein-protein interactions and implications in disease state. Biochim Biophys Acta 2009, 1791:646-658. 2757135, 19286473.
10. Gavish M, Bachman AN, Shoukrun R, Katz Y, Veenman L, Weisinger G, Weizman A. Enigma of the peripehral benzodiazepine receptor. Pharmacol Rev 1999, 51:629-650.
11. Pini S, Martini C, Abelli M, Muti M, Gesi C, Montali M, Chelli B, Lucacchini A, Cassano GB. Peripheral-type benzodiazepine receptor binding sites in platelets of patients with panic disorder associated to separation anxiety symptoms. Psychopharmacology 2005, 181:407-411. 10.1007/s00213-005-2247-x, 15830231.
12. Bazzichi L, Giannaccini G, Betti L, Mascia G, Fabbrini L, Italiani P, De Feo F, Giuliano T, Giacomelli C, Rossi A, Lucacchini A, Bombardieri S. Alteration of serotonin transporter density and activity in fibromyalgia. Arthritis Res Ther 2006, 8:R99. 10.1186/ar1982, 1779383, 16790074.
13. Bazzichi L, Giannaccini G, Betti L, Italiani P, Fabbrini L, Defeo F, Giacomelli C, Giuliano T, Rossi A, Uccelli A, Giusti L, Mascia G, Lucacchini A, Bombardieri S. Peripheral benzodiazepine receptors on platelets of fibromyalgic patients. Clin Biochem 2006, 39:867-872. 10.1016/j.clinbiochem.2006.06.002, 16919618.
14. Park S, Harrold JA, Widdowson PS, Williams G. Increased binding at 5-HT1A, 5-HT1B and 5-HT2A receptors and 5-HT transporters in diet-induced obese rats. Brain Res 1999, 847:90-97. 10.1016/S0006-8993(99)02055-7, 10564740.
15. Huang XF, Huang X, Han M, Chen F, Storlien L, Lawrence AJ. 5-HT2A/2C receptor and 5-HT transporter densities in mice prone or resistant to chronic high-fat diet-induced obesity: a quantitative autoradiography study. Brain Res 2004, 1018:227-235. 10.1016/j.brainres.2004.05.093, 15276882.
16. Considine RV, Sinha MK, Heiman ML. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 1996, 334:292-295. 10.1056/NEJM199602013340503, 8532024.
17. Ramos EJB, Meguid MM, Campos ACL, Coelho JCU. Neuropeptide Y, a-melanocyte-stimulating hormone and monoamines in food intake regulation. Nutrition 2005, 21:269-279. 10.1016/j.nut.2004.06.021, 15723758.
18. Jequiert E. Leptin signaling, adiposity and energy balance. Ann NY Acad Sci 2002, 967:379-388. 10.1111/j.1749-6632.2002.tb04293.x, 12079865.
19. Kjerrulf M, Berke Z, Aspegren A, Umaerus M, Nilsson T, Svensson L, Camejo-Hurt E. Reduced cholesterol accumulation by leptin deficient (ob/ob) mouse macrophages. Inflamm Res 2006, 55:300-309. 10.1007/s00011-006-0087-8, 16955393.
20. Giannaccini G, Giusti L, Santini F, Marsili A, Betti L, Mascia G, Pelosini C, Baroni S, Ciregia F, Fabbrini L, Lucacchini A, Vitti P, Pinchera A. Tubby protein in human lymphocytes from normal weight and obese subjects. Clin Biochemistry 2007, 40:806-809.
21. Matarese G, La Cava A. The intricate interface between immune system and metabolism. Trends Immunol 2004, 25:193-200. 10.1016/j.it.2004.02.009, 15039046.
22. Marazziti D, Rossi A, Dell'osso L, Palego L, Placidi GP, Giannaccini G, Lucacchini A, Cassano GB. Decreased platelet [3H]-paroxetine binding in untreated panic disorder patients. Life Sci 1999, 65:2735-2741. 10.1016/S0024-3205(99)00542-1, 10622283.
23. Marazziti D, Dell'osso B, Baroni S, Masala I, Di Nasso E, Giannaccini G, Conti L. Decreased density of peripheral benzodiazepine receptors in psychiatric patients after a suicide attempt. Life Sci 2005, 77:3268-3275. 10.1016/j.lfs.2005.04.031, 16014308.
24. Marazziti D, Dell'osso L, Rossi A, Masala I, Baroni S, Armani A, Giannaccini G, Di Nasso E, Lucacchini A, Cassano GB. Decreased platelet [3H]-paroxetine binding sites in suicide attempters. Psychiatry Res 2001, 103:125-131. 10.1016/S0165-1781(01)00281-5, 11549401.
25. Charnay Y, Cusin I, Vallet PG, Muzzin P, Rohner-Jeanrenaud F, Bouras C. Intracerebroventricular infusion of leptin decreases serotonin transporter binding sites in the frontal cortex of the rat. Neurosci Lett 2000, 283:89-92. 10.1016/S0304-3940(00)00951-4, 10739882.
26. Giannaccini G, Betti L, Palego L, Schmid L, Fabbrini L, Pelosini C, Gargini C, Da Valle Y, Lanza M, Marsili A, Maffei M, Santini F, Vitti P, Pinchera A, Lucacchini A. Human Serotonin Transporter Expression during Megakaryocytic Differentiation of MEG-01 Cells. Neurochem Res 2010, 35:628-635. 10.1007/s11064-009-0112-8, 20041293.
27. Hurley JH, Zhang S, Bye LS, Marshall MS, Depaoli-Roach AA, Guan K, Fox AP, Yu L. Insulin signaling inhibits the 5-HT2C receptor in choroid plexus via MAP-kinase. BMC Neurosci 2003, 9:4-10.
28. Giatti S, Pesaresi M, Cavaletti G, Bianchi R, Carozzi V, Lombardi R, Maschi O, Lauria G, Garcia-Segura LM, Caruso D, Melcangi RC. Neuroprotective effects of a ligand of translocator protein-18KDa (Ro5-4864) in experimental diabetic neuropathy. Neuroscience 2009, 164:520-529. 10.1016/j.neuroscience.2009.08.005, 19665520.
29. Rotondo A, Giannaccini G, Betti L, Chiellini G, Marazziti D, Martini C, Lucacchini A, Cassano GB. The serotonin transporter from human brain: Purification and partial characterization. Neurochem Int 1996, 28:299-307. 10.1016/0197-0186(95)00080-1, 8813248.
30. Ramacciotti CE, Coli E, Paoli R, Marazziti D, Dell'osso L. Serotonergic activity measured by platelet [3H]-paroxetine binding in patients with eating disorders. Psychiatry Res 2003, 118:33-38. 10.1016/S0165-1781(03)00059-3, 12759159.
31. Selleri S, Bruni F, Costagli C, Costanzo A, Guerrini G, Ciciani G, Costa B, Martini C. 2-Arylpyrazolo[1,5-a]pyrimidin-3-yl Acetamides. New Potent and Selective Peripheral Benzodiazepine Receptor Ligands. Bioorg Med Chem 2001, 9:2661-2671. 10.1016/S0968-0896(01)00192-4, 11557354.
32. Martini C, Chelli B, Betti L, Montali M, Mancuso M, Giannaccini G, Rocchi A, Murri L, Siciliano G. Peripheral benzodiazepine binding sites in platelets of patients affected by mitochondrial diseases and large scale mitochondrial DNA rearrangements. Mol Med 2002, 8:841-846. 2039969, 12606819.
33. Mc Pherson GA. KINETIC, EBDA, LIGAND, LOWRY: A collection of radio-ligand binding analysis programs. 1985, Biosoft, Cambridge. U.K.